tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Fuso Pharmaceutical Reports Q1 2025 Financial Results with Increased Sales but Declining Profits

Story Highlights
Fuso Pharmaceutical Reports Q1 2025 Financial Results with Increased Sales but Declining Profits

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) just unveiled an update.

Fuso Pharmaceutical Industries, Ltd. reported its non-consolidated financial results for the three months ended June 30, 2025, showing a 6% increase in net sales compared to the previous year. However, the company experienced a significant decline in operating profit, ordinary profit, and net profit by 48.1%, 28.8%, and 26.9% respectively, indicating challenges in maintaining profitability despite increased sales.

More about Fuso Pharmaceutical Industries,Ltd.

Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry and is listed on the Tokyo Stock Exchange. The company focuses on the development and sale of pharmaceutical products.

Average Trading Volume: 17,193

Technical Sentiment Signal: Hold

Current Market Cap: Yen19.09B

For an in-depth examination of 4538 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1